Tatva Chintan Pharma Chem Announces 30th AGM on September 25, 2026
Tatva Chintan Pharma Chem Limited will hold its 30th Annual General Meeting on September 25, 2026, at 4:00 PM IST via VC/OAVM. Newspaper advertisements were published on August 28, 2026, detailing the AGM notice, record date, book closure, and e-voting information.
This is a standard corporate compliance announcement regarding the scheduling of the AGM. It does not involve any new financial performance, strategic decisions, or material events that would significantly impact the company's stock or operations.
The announcement is a routine disclosure regarding the upcoming Annual General Meeting and does not contain any new financial information or significant business updates that would indicate a positive or negative sentiment.
Tatva Chintan Pharma Chem Limited has announced its 30th Annual General Meeting (AGM) will be held on Friday, September 25, 2026, at 04:00 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The company has published newspaper advertisements in Financial Express (English) and Vadodara Samachar (Gujarati) on August 28, 2026, to provide notice of the AGM. These advertisements include details regarding the record date, book closure, and remote e-voting. The information will also be available on the company's website, www.tatvachintan.com.
This announcement serves as a formal disclosure under Regulation 30, 44, and 47 of the SEBI Listing Regulations and in compliance with Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administration) Rules, 2014. Ishwar Nayi, Company Secretary and Compliance Officer, signed the filing.
What to do with a filing like this
Tatva Chintan Pharma Chem Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tatva Chintan Pharma Chem Limited. Read the original for the full detail.